Anthony Harris

3.3k total citations
24 papers, 1.5k citations indexed

About

Anthony Harris is a scholar working on Molecular Medicine, Molecular Biology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Anthony Harris has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Medicine, 8 papers in Molecular Biology and 8 papers in Applied Microbiology and Biotechnology. Recurrent topics in Anthony Harris's work include Antibiotic Resistance in Bacteria (11 papers), Antibiotic Use and Resistance (8 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Anthony Harris is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Antibiotic Use and Resistance (8 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Anthony Harris collaborates with scholars based in United States, United Kingdom and Israel. Anthony Harris's co-authors include Pranita D. Tamma, Yehuda Carmeli, Sara E. Cosgrove, Matthew H. Samore, Katherine E Goodman, Keith S. Kaye, Ebbing Lautenbach, Jennifer Han, Tsigereda Tekle and Patricia J. Simner and has published in prestigious journals such as The EMBO Journal, Clinical Infectious Diseases and Genetics.

In The Last Decade

Anthony Harris

23 papers receiving 1.5k citations

Peers

Anthony Harris
Eric Wenzler United States
Belén Gutiérrez‐Gutiérrez Spain
Cecília G Carvalhaes United States
Angela Raffaella Losito Italy
Angela Gomez‐Simmonds United States
Eric Cober United States
Andrew Denisuik Canada
Mark E. Jones United States
Melanie Baxter Canada
Mari Ariyasu Japan
Eric Wenzler United States
Anthony Harris
Citations per year, relative to Anthony Harris Anthony Harris (= 1×) peers Eric Wenzler

Countries citing papers authored by Anthony Harris

Since Specialization
Citations

This map shows the geographic impact of Anthony Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Harris more than expected).

Fields of papers citing papers by Anthony Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Harris. The network helps show where Anthony Harris may publish in the future.

Co-authorship network of co-authors of Anthony Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Harris. A scholar is included among the top collaborators of Anthony Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Harris. Anthony Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baghdadi, Jonathan, Katherine E Goodman, Laurence S. Magder, et al.. (2025). Association Between Delayed Broad-Spectrum Gram-negative Antibiotics and Clinical Outcomes: How Much Does Getting It Right With Empiric Antibiotics Matter?. Clinical Infectious Diseases. 80(5). 949–958. 3 indexed citations
2.
Bergman, Yehudit, Emily Jacobs, Jennifer Lu, et al.. (2025). Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States. Antimicrobial Agents and Chemotherapy. 69(3). e0125824–e0125824. 1 indexed citations
3.
Harris, Anthony, Theodora Sideri, Elçin Ünal, et al.. (2024). Multi-signal regulation of the GSK-3β homolog Rim11 controls meiosis entry in budding yeast. The EMBO Journal. 43(15). 3256–3286.
4.
Harris, Anthony & Elçin Ünal. (2023). The transcriptional regulator Ume6 is a major driver of early gene expression during gametogenesis. Genetics. 225(2). 7 indexed citations
5.
Laureau, Raphaëlle, Jia‐Xing Yue, Matteo De Chiara, et al.. (2020). Meiotic Cells Counteract Programmed Retrotransposon Activation via RNA-Binding Translational Repressor Assemblies. Developmental Cell. 56(1). 22–35.e7. 7 indexed citations
6.
7.
Player, Audrey, et al.. (2017). Identification of candidate genes associated with triple negative breast cancer. Genes & Cancer. 8(7-8). 659–672. 21 indexed citations
8.
Arbefeville, Sophie, et al.. (2016). PasteurellamultocidaBacteremia With Associated Knee Arthroplasty Infection in an 80-Year-Old Caucasian Man. Laboratory Medicine. 47(3). 241–245. 2 indexed citations
9.
Dukowic‐Schulze, Stefanie, Anthony Harris, & Changbin Chen. (2016). Immunolocalization on Whole Anther Chromosome Spreads for Male Meiosis. Methods in molecular biology. 1429. 161–175. 1 indexed citations
10.
Goodman, Katherine E, Justin Lessler, Sara E. Cosgrove, et al.. (2016). A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum β-Lactamase–Producing Organism. Clinical Infectious Diseases. 63(7). 896–903. 132 indexed citations
11.
Tamma, Pranita D., et al.. (2016). Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clinical Infectious Diseases. 64(3). 257–264. 288 indexed citations
12.
Tamma, Pranita D., Jennifer Han, Clare Rock, et al.. (2015). Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase Bacteremia. Clinical Infectious Diseases. 60(9). 1319–1325. 224 indexed citations
13.
Dukowic‐Schulze, Stefanie, Anthony Harris, Junhua Li, et al.. (2013). Comparative Transcriptomics of Early Meiosis in Arabidopsis and Maize. Journal of genetics and genomics. 41(3). 139–152. 32 indexed citations
14.
Greenidge, André, et al.. (2010). Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14posCD163highHLA‐DRlow) following cardiopulmonary bypass. Cytometry Part B Clinical Cytometry. 78B(5). 357–360. 6 indexed citations
15.
Johnson, J. Kristie, Richard A. Venezia, O. Colin Stine, et al.. (2009). The Role of Patient‐to‐Patient Transmission in the Acquisition of Imipenem‐ResistantPseudomonas aeruginosaColonization in the Intensive Care Unit. The Journal of Infectious Diseases. 200(6). 900–905. 51 indexed citations
16.
Sunenshine, Rebecca, Marc‐Oliver Wright, Lisa L. Maragakis, et al.. (2007). Multidrug-resistantAcinetobacterInfection Mortality Rate and Length of Hospitalization. Emerging infectious diseases. 13(1). 97–103. 340 indexed citations
17.
Kaye, Keith S., Anthony Harris, Matthew H. Samore, & Yehuda Carmeli. (2005). The Case-Case-Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance. Infection Control and Hospital Epidemiology. 26(4). 346–351. 132 indexed citations
18.
Harris, Anthony, Carlos Torres‐Viera, Lata Venkataraman, et al.. (1999). Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosa. Clinical Infectious Diseases. 28(5). 1128–1133. 158 indexed citations
19.
Harris, Anthony, Michelle Lally, & Mary Albrecht. (1998). Legionella bozemaniiPneumonia in Three Patients with AIDS. Clinical Infectious Diseases. 27(1). 97–99. 19 indexed citations
20.
Gagnon, Raymonde F., et al.. (1989). The Activity of Rifampin and Analogs against Staphylococcus epidermidis Biofilms in a CAPD Environment Model. American Journal of Nephrology. 9(5). 414–420. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Wenzler Breakdown of academic impact, for papers by Belén Gutiérrez‐Gutiérrez Breakdown of academic impact, for papers by Cecília G Carvalhaes Breakdown of academic impact, for papers by Angela Raffaella Losito Breakdown of academic impact, for papers by Angela Gomez‐Simmonds Breakdown of academic impact, for papers by Eric Cober Breakdown of academic impact, for papers by Andrew Denisuik Breakdown of academic impact, for papers by Mark E. Jones Breakdown of academic impact, for papers by Melanie Baxter Breakdown of academic impact, for papers by Mari Ariyasu
Rankless by CCL
2026